| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.27B | 42.84B | 44.56B | 46.43B | 40.76B | 36.50B |
| Gross Profit | 8.04B | 7.72B | 7.81B | 10.43B | 8.98B | 6.21B |
| EBITDA | 2.77B | 2.50B | 2.88B | 5.47B | 4.16B | 1.43B |
| Net Income | 2.11B | 2.13B | 1.69B | 3.06B | 2.57B | 1.28B |
Balance Sheet | ||||||
| Total Assets | 52.89B | 52.06B | 58.19B | 54.04B | 52.52B | 45.57B |
| Cash, Cash Equivalents and Short-Term Investments | 6.93B | 6.70B | 9.60B | 8.33B | 8.14B | 8.41B |
| Total Debt | 7.15B | 5.74B | 5.90B | 6.25B | 6.62B | 6.84B |
| Total Liabilities | 21.80B | 20.48B | 22.18B | 21.82B | 23.67B | 19.35B |
| Stockholders Equity | 30.59B | 31.11B | 35.60B | 31.86B | 28.64B | 26.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.84B | 2.42B | 1.02B | 335.00M | 1.04B |
| Operating Cash Flow | 0.00 | 2.73B | 2.87B | 2.07B | 1.22B | 2.31B |
| Investing Cash Flow | 0.00 | 590.00M | -683.00M | -1.07B | -849.00M | -671.00M |
| Financing Cash Flow | 0.00 | -6.05B | -1.05B | -896.00M | -729.00M | -1.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥20.08B | 5.36 | ― | 2.73% | 8.19% | 22.55% | |
74 Outperform | ¥343.57B | 12.83 | ― | 3.26% | -7.77% | 58.84% | |
69 Neutral | ¥20.98B | 11.22 | ― | 6.00% | -5.76% | 56.13% | |
68 Neutral | ¥16.98B | 10.27 | ― | 1.71% | -4.31% | 8.40% | |
66 Neutral | ¥27.73B | 21.77 | ― | 4.13% | -2.96% | ― | |
64 Neutral | ¥33.35B | -185.54 | ― | 5.02% | -13.64% | -45.74% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |